Benserazide·HCl (Ro 4-4602) (CAS 14919-77-8)
QUICK LINKS
Benserazide·HCl (Ro 4-4602) is a compound that is extensively used in biochemical research, particularly in studies concerning amino acid decarboxylation. This compound serves as an inhibitor of aromatic L-amino acid decarboxylase (AAAD), an enzyme responsible for the decarboxylation of L-DOPA to dopamine. By inhibiting this enzyme, Benserazide·HCl (Ro 4-4602) is instrumental in research that investigates the metabolism and regulation of neurotransmitter precursors. The hydrochloride salt form of this compound improves its solubility in aqueous solutions, facilitating its use in various experimental setups, including in vitro enzyme assays. Additionally, benserazide hydrochloride is utilized in studies examining the transport of amino acids across the blood-brain barrier, as its presence can influence the uptake of other amino acids or related compounds.
Benserazide·HCl (Ro 4-4602) (CAS 14919-77-8) References
- Influence of dopaminergic agonists and antagonists on serum prolactin concentrations in the rat. | Horowski, R. and Gräf, HJ. 1976. Neuroendocrinology. 22: 273-86. PMID: 1028957
- Dopaminergic control of adenohypophyseal growth after oestrogens: negative results with L-DOPA, RO-4-4602, alpha-methyl-DOPA, apomorphine, haloperidol, pyridoxine and cyproheptadine. | Schreiber, V., et al. 1978. Physiol Bohemoslov. 27: 308-12. PMID: 151287
- The actions of dihydroxyphenylalanine and dihydroxyphenylserine on the sleep-wakefulness cycle of the rat after peripheral decarboxylase inhibition. | Altier, H., et al. 1975. Br J Pharmacol. 54: 101-6. PMID: 166716
- Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease. | Merims, D. and Giladi, N. 2008. Parkinsonism Relat Disord. 14: 273-80. PMID: 17988927
- Streptozotocin-induced diabetes reduces brain serotonin synthesis in rats. | Trulson, ME., et al. 1986. J Neurochem. 46: 1068-72. PMID: 2419504
- Inhibition of brain dopa-decarboxylase by RO 4-4602 infused ICV blocks alcohol drinking induced in rats by cyanamide. | Miñano, FJ. and Myers, RD. 1989. Psychopharmacology (Berl). 98: 176-82. PMID: 2502790
- Interaction of tetrahydropapaveroline with inhibition of dopa-decarboxylase by Ro 4-4602 in brain: effects on alcohol drinking in the rat. | Miñano, FJ., et al. 1989. Alcohol. 6: 133-7. PMID: 2713086
- A comparison of the discriminative stimulus properties of l-5-hydroxytryptophan in the presence of either citalopram or Ro 4-4602. | Winter, JC. and Rabin, RA. 1988. Pharmacol Biochem Behav. 30: 613-6. PMID: 3264918
- Single-dose study of slow release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's disease. | Marion, MH., et al. 1987. Adv Neurol. 45: 493-6. PMID: 3548262
- Differential effect of benserazide (Ro4-4602) on the concentration of indoleamines in rat pineal and hypothalamus. | Arendt, J., et al. 1981. Br J Pharmacol. 72: 257-62. PMID: 7214095
- Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism. | Pinder, RM., et al. 1976. Drugs. 11: 329-77. PMID: 782834
- Competitive inhibition of catechol O-methyltransferase by RO-4-4602. | Buu, NT., et al. 1977. Can J Biochem. 55: 771-3. PMID: 890572
- Reinstatement of vaginal cycles in aged female rats. | Linnoila, M. and Cooper, RL. 1976. J Pharmacol Exp Ther. 199: 477-82. PMID: 988180
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Benserazide·HCl (Ro 4-4602), 100 mg | sc-200723 | 100 mg | $26.00 | |||
Benserazide·HCl (Ro 4-4602), 1 g | sc-200723A | 1 g | $85.00 |